High-risk AI systems in medicine: Navigating the EU AI Act for MedTech organisations

AI is transforming the medtech industry. Alexine Hui Ern Mota reports on the data protection considerations and how to operationalise high-risk AI.

Daniela Fábián, Founder and Executive director of Fabian Privacy Legal, and Luca Nevano, Chief Privacy and Data Protection Officer of a MedTech multinational corporation Becton Dickinson (BD) addressed this topic at PL&B’s 38th International Conference in July.

As the deadline for compliance with the European Union Artificial Intelligence Act (AI Act) by organisations using high-risk AI systems is approaching, this session on AI and privacy law was invaluable for providing practical insights to MedTech companies on the action they should be undertaking in preparation for the rest of the AI Act’s obligations to become applicable.

Continue Reading

International Report subscribers, please login to access the full article

LOGIN

If you wish to subscribe, please see our subscription information.

Subscribe